These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 21541295)
1. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line. Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295 [TBL] [Abstract][Full Text] [Related]
2. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling. Park J; Kim S; Joh J; Remick SC; Miller DM; Yan J; Kanaan Z; Chao JH; Krem MM; Basu SK; Hagiwara S; Kenner L; Moriggl R; Bunting KD; Tse W Oncotarget; 2016 Jul; 7(28):43960-43973. PubMed ID: 27259262 [TBL] [Abstract][Full Text] [Related]
3. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Behera R; Kumar V; Lohite K; Karnik S; Kundu GC Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637 [TBL] [Abstract][Full Text] [Related]
4. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer. Mai J; Huang Y; Mu C; Zhang G; Xu R; Guo X; Xia X; Volk DE; Lokesh GL; Thiviyanathan V; Gorenstein DG; Liu X; Ferrari M; Shen H J Control Release; 2014 Aug; 187():22-9. PubMed ID: 24818768 [TBL] [Abstract][Full Text] [Related]
6. CD24 controls Src/STAT3 activity in human tumors. Bretz NP; Salnikov AV; Perne C; Keller S; Wang X; Mierke CT; Fogel M; Erbe-Hofmann N; Schlange T; Moldenhauer G; Altevogt P Cell Mol Life Sci; 2012 Nov; 69(22):3863-79. PubMed ID: 22760497 [TBL] [Abstract][Full Text] [Related]
7. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway. Wang J; Xu J; Xing G Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):771-779. PubMed ID: 28910973 [TBL] [Abstract][Full Text] [Related]
8. A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells. Jaganathan S; Yue P; Paladino DC; Bogdanovic J; Huo Q; Turkson J PLoS One; 2011 May; 6(5):e19605. PubMed ID: 21573184 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma. Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220 [TBL] [Abstract][Full Text] [Related]
11. Characterization of STAT3 activation and expression in canine and human osteosarcoma. Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models. Gupta P; Srivastava SK BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293 [TBL] [Abstract][Full Text] [Related]
13. Small molecule 1'-acetoxychavicol acetate suppresses breast tumor metastasis by regulating the SHP-1/STAT3/MMPs signaling pathway. Wang J; Zhang L; Chen G; Zhang J; Li Z; Lu W; Liu M; Pang X Breast Cancer Res Treat; 2014 Nov; 148(2):279-89. PubMed ID: 25301089 [TBL] [Abstract][Full Text] [Related]
14. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells. Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417 [TBL] [Abstract][Full Text] [Related]
15. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition. Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice. Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845 [TBL] [Abstract][Full Text] [Related]
17. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512 [TBL] [Abstract][Full Text] [Related]
18. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1. Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930 [TBL] [Abstract][Full Text] [Related]
19. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin. Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Aceto N; Sausgruber N; Brinkhaus H; Gaidatzis D; Martiny-Baron G; Mazzarol G; Confalonieri S; Quarto M; Hu G; Balwierz PJ; Pachkov M; Elledge SJ; van Nimwegen E; Stadler MB; Bentires-Alj M Nat Med; 2012 Mar; 18(4):529-37. PubMed ID: 22388088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]